The Facts

 

Why?

New Zealand has the 7th highest incidence of breast cancer in the world. Mortality from breast cancer is 20% higher in New Zealand than in Australia.

Breast Cancer is taking two of our nation’s women from us every day, whilst one woman is diagnosed with the disease every three hours. Our support has helped to slow the death rate by 1% per year with 87% of women diagnosed with early breast cancer now surviving more than five years. For the remaining 13% there is currently no cure and now more than ever our focus remains on this group and the 20-30% who subsequently go on to develop advanced breast cancer.

 

 

#1

Cancer for Women

3,000

Diagnosed each year

20

Men diagnosed each year too

 

 

Where does the
money go?

Since its establishment, Breast Cancer Cure has funded many significant research projects in New Zealand, totaling close to $10 million in grants due to the lack of government funding directly into breast cancer. Some of the New Zealand institutions to benefit from Breast Cancer Cure's work include the University of Canterbury, the University of Otago, The Liggins Institute in Auckland, the Malaghan Institute in Wellington, University of Auckland and Massey University.

View Research Projects →

Publicly funded new medicines

 

 

Our research partnerships

As part of the Breast Cancer Research partnership with the Health Research Council of NZ and the Breast Cancer Foundation NZ, we have jointly funded $2.4M in the last four years and employed the equivalent of approximately 30 FTE researchers across 25 institutions directly or through collaboration.

Meet the researchers →

 

"We are slowing the death rate down by 1% per year."

– Phillipa Green

 

 

Summary

We support research into finding a "cure" for breast cancer by making the disease one that women can endure and survive by funding novel research into:  prevention, earlier detection, predictive and prognostic diagnosis, appropriate and tailored treatment and broadening the knowledge base around breast cancer and treatment with a focus on the 17% with poorer outcomes and the 30% with recurring or metastatic cancer.

We’re committed to achieving our goal of finding a cure for breast cancer and with your support and involvement, we believe that is a very achievable goal.